Evidence-based pharmacologic treatment of pediatric bipolar disorder

Robert L. Findling

Research output: Contribution to journalArticlepeer-review

Abstract

Pharmacotherapy is an important component of treatment for children and adolescents with bipolar disorder. The body of evidence supporting safe and effective treatments in this population is growing. Available data provide information on the risks and benefits of pharmacologic agents used for acute manic, mixed, and depressive episodes as well as for maintenance treatment. Lithium, anticonvulsants, and antipsychotics comprise the armamentarium for treating pediatric bipolar disorder. When selecting treatment, clinicians must consider the efficacy and side effect profile of potential pharmacotherapies, as well as the patient's history, including the presence of comorbidities, in order to develop a treatment plan that will ensure optimal outcomes.

Original languageEnglish (US)
Article numbere02
JournalJournal of Clinical Psychiatry
Volume77
DOIs
StatePublished - 2016

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Evidence-based pharmacologic treatment of pediatric bipolar disorder'. Together they form a unique fingerprint.

Cite this